Clinical Trial Update: In-Patient Study In Schizophrenic Patients [Phase 1]

View source ↗

Summary

A Phase 1 in-patient trial for schizophrenia sponsored by GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED